Theresia Ambrose Ottaru

Dr. Theresia Ambrose Ottaru

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
TOTheresia Ambrose Ottaru
Theresia Ambrose Ottaru
GKGideon P. Kwesigabo
Gideon P. Kwesigabo
ZBZeeshan Butt
Zeeshan Butt
MCMatthew Caputo
Matthew Caputo
PCPilly Chillo
Pilly Chillo
CHClaudia A. Hawkins
Claudia A. Hawkins
With improved survival, adults living with HIV (ALHIV) are increasingly likely to experience age-related and HIV-related comorbidities, including renal insufficiency. Other risk factors for renal insufficiency (high blood pressure (BP), obesity, diabetes, and dyslipidemia) are also growing more common among ALHIV. To determine the prevalence of renal insufficiency (defined as an eGFR < 60 mL/min/1.73 m2) and factors associated with reduced eGFR, we conducted a cross-sectional study at six HIV clinics in Dar-es-Salaam, Tanzania. We applied multivariable (MV) ordinal logistic regression models to identify factors associated with reduced eGFR and examined the interaction of age with BP levels. Among the 450 ALHIV on ART analyzed [26% males; median age 43 (IQR: 18–72) years; 89% on tenofovir-containing ART; 88% HIV viral load ≤50 copies/mL], 34 (7.5%) had renal insufficiency. Prevalence was higher among males (12%) vs. females (6%), p = 0.03; ALHIV ≥50 (21%) vs. <50 years (2.5%), p < 0.001; those with high [≥130/80 mmHg (15%)] vs. normal [<120/80 mmHg (4%)] BP, p < 0.01 and those with dyslipidemia (10%) vs. those without (4.5%), p < 0.03. After adjusting for covariates, age (in years) was the only covariate with a statistically significant association with reduced eGFR (OR = 1.09 (1.07–1.12), p < 0.001). No significant interaction between age and BP was found. Interventions to increase routine screening for renal insufficiency, especially among older ALHIV, and improve BP control are critical to reducing kidney disease-related morbidity and mortality.

11 January 2022 in Global Heart
Verified
Journal Article
Open access
PDF file
TOTheresia Ambrose Ottaru
Theresia Ambrose Ottaru
GKGideon P. Kwesigabo
Gideon P. Kwesigabo
ZBZeeshan Butt
Zeeshan Butt
ARAdovich Rivera
Adovich Rivera
PCPilly Chillo
Pilly Chillo
CHClaudia A. Hawkins
Claudia A. Hawkins
Ageing adults living with HIV (ALHIV) have increased risk of cardiovascular diseases as a result of HIV-infection-related chronic immune activation and inflammatory responses. Cardiovascular health index (CVHI) is a valid and relatively simple index for assessing the cardiovascular health (CVH) of the general population. Use of this index among ALHIV in Sub Saharan Africa, a resource-restricted setting where it could be mostly beneficial, remains limited. Understanding of the distribution and associated factors may inform the design of optimal interventions to improve CVH of ALHIV. We aimed to assess the distribution and factors associated with CVHI scores among ALHIV in an urban setting in Tanzania. A cross-sectional study was conducted among ALHIV on antiretroviral therapy at six HIV clinics in Dar-es-Salaam, Tanzania. We summed the score of each of the seven CVHI metric to obtain the overall CVHI score and assessed the distribution of the score by sex. We then categorized the overall score into ideal (5–7), intermediate (3–4) and poor (<3) CVH categories and performed ordinal regression to identify CVHI score associated factors. In all, 629 ALHIV [mean age of 43.5(SD ± 11.2) years] were enrolled. Most had ideal levels of blood glucose (96.2%) and smoking status (83.4%) while less than half had ideal BMI (48.1%), blood pressure (BP) (43.9%) and dietary intake (7.8%). Less than half (47.6%) showed ideal CVH, while less than 1% had all seven metrics at ideal level. Older age (0.96(95%CI:0.95–0.97), p-value < 0.001), being retired/unemployed (0.59(95%CI:0.43–0.81), p-value < 0.01), being employed (0.76(95%CI:0.62–0.94), p-value = 0.01) alcohol use (0.41(95%CI:0.21–0.80), p-value = 0.01) and presence of non-communicable disease comorbidities (0.68(95%CI:0.48–0.97), p-value = 0.04) had significant lower odds of ideal CVH. Based on our findings, interventions to improve CVH of ALHIV should target BP management, health education on diet for BMI control and reduction in alcohol consumption, particularly among ageing ALHIV with comorbidities.

9 February 2024 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
TOTheresia Ambrose Ottaru
Theresia Ambrose Ottaru
CWChristine V. Wood
Christine V. Wood
ZBZeeshan Butt
Zeeshan Butt
CHClaudia Hawkins
Claudia Hawkins
LHLisa R. Hirschhorn
Lisa R. Hirschhorn
GKGideon P. Kwesigabo
Gideon P. Kwesigabo
For adults living with HIV (ALHIV) and comorbidities, access to comprehensive healthcare services is crucial to achieving optimal health outcomes. This study aims to describe lived experiences, challenges, and coping strategies for accessing care for hypertension and/or diabetes (HTN/DM) in HIV care and treatment clinics (CTCs) and other healthcare settings. We conducted a qualitative study that employed a phenomenological approach between January and April 2022 using a semi-structured interview guide in six HIV CTCs in Dar es Salaam, Tanzania. We purposively recruited 33 ALHIV with HTN (n = 16), DM (n = 10), and both (n = 7). Thematic content analysis was guided by the 5As framework of access to care. The majority of the participants were females, between the ages of 54–73, and were recruited from regional referral hospitals. HIV CTCs at regional referral hospitals had more consistent provision of HTN screening services compared to those from district hospitals and health centers. Participants sought HTN/DM care at non-CTC health facilities due to the limited availability of such services at HIV CTCs. However, healthcare delivery for these conditions was perceived as unaccommodating and poorly coordinated. The need to attend multiple clinic appointments for the management of HTN/DM in addition to HIV care was perceived as frustrating, time-consuming, and financially burdensome. High costs of care and transportation, limited understanding of comorbidities, and the perceived complexity of HTN/DM care contributed to HTN/DM treatment discontinuity. As a means of coping, participants frequently monitored their own HTN/DM symptoms at home and utilized community pharmacies and dispensaries near their residences to check blood pressure and sugar levels and obtain medications. Participants expressed a preference for non-pharmaceutical approaches to comorbidity management such as lifestyle modification (preferred by young participants) and herbal therapies (preferred by older participants) because of concerns about side effects and perceived ineffectiveness of HTN/DM medications. Participants also preferred integrated care and focused patient education on multimorbidity management at HIV CTCs. Our findings highlight significant barriers to accessing HTN/DM care among ALHIV, mostly related to affordability, availability, and accessibility. Integration of NCD care into HIV CTCs, could greatly improve ALHIV health access and outcomes and align with patient preference.

27 December 2019 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
UEUwezo Edward
Uwezo Edward
HSHendry R. Sawe
Hendry R. Sawe
JMJuma A. Mfinanga
Juma A. Mfinanga
TOTheresia Ambrose Ottaru
Theresia Ambrose Ottaru
MKMichael Kiremeji
Michael Kiremeji
EWEllen J. Weber
Ellen J. Weber
Background: Elevated serum lactate levels have been shown in numerous studies to be associated with serious adverse events, including mortality. Point of care lactate level is increasingly available in resource-limited emergency department (ED) settings. However, little is known about the predictive ability of for serious adverse events. Aim of the study: We aimed to describe the utility of serum lactate level as a predictor of 24-h serious adverse events among adult patients presenting at the Emergency Medicine Department (EMD) of Muhimbili National Hospital (MNH) and MUHAS Academic Medical Center (MAMC). Methods: This was a prospective observational study involving adult patients presenting to the EMD-MNH and MAMC from 1 September 2018 and 31 October 2018. Eligible patients with at least one lactate level test drawn while in the ED were examined in terms of their demographics, relevant clinical characteristics, and any serious adverse event (SAE) within 24 h of arrival. The sensitivity and specificity of lactate level to predict outcomes of interest were determined using the best cut-off point constructed from AUROC to see how well lactate level could discriminate which patients would have adverse events in the next 24 h. Categorical and continuous variables were compared with the chi-square test and two-sample t test, respectively. Results: We screened 2057 (20.9%) out of 9828 patients who presented during study period, and enrolled 387 (18.8%). The overall median age was 54 years (interquartile range 40–68 years) and 206 (53.2%) were male. Using local triaging system, a total of 322 (83.2%) was triaged as an emergency category. The mean lactate level was 3.2 ± 3.6 mmol/L, 65 (16.8%) patients developed at least one SAE, with 42 (11%) who required ICU/HDU, 37 (10%) needed ventilator support, 10 (3%) required inotropes, and 9 (2%) developed cardiac arrest. The overall 24-h mortality was 28 (7%). The AUC of serum lactate level for overall 24-h mortality was 0.801 (95%CI, 0.7–0.9, P ≤ 0.001). At the optimal cutoff value (3.8 mmol/L), lactate level had a sensitivity and specificity for 24-h mortality of 64% and 85%, respectively. Mortality of the high-lactate level group (33.8 mmol/L) was significantly higher than that of the low-lactate level group (< 3.8 mmol/L), 23.8% vs. 2.9%, respectively (95%CI 3.8–17.2, p < 0.001), with the relative risk of mortality in the high-lactate level group being 8.1 times higher compared to the low-lactate level group. Conclusion: The utility of lactate level in predicting mortality was similar to that seen in high-resource settings. A serum lactate level of 33.8 mmol/L predicted 24-h serious adverse events in unselected patients seen in the high-acuity area of our ED. Incorporating serum lactate level in ED in lower- and middle-income countries (LMICs) can help identify patients at risk of developing serious adverse events.

5 November 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ESElihuruma Eliufoo Stephano
Elihuruma Eliufoo Stephano
LRLinus Paul Rweyemamu
Linus Paul Rweyemamu
TYTian Yusheng
Tian Yusheng
LYLi Yamin
Li Yamin
TOTheresia Ambrose Ottaru
Theresia Ambrose Ottaru
CMChristopher Mbotwa
Christopher Mbotwa
Human immunodeficiency virus (HIV) infection remains a significant global challenge, particularly in resource-limited settings where access to healthcare services is constrained. Despite substantial efforts to combat HIV, the uptake of screening among adolescent girls and young women (AGYW) remains sub-optimal. This study aimed to determine the prevalence of HIV screening and identify the factors associated with screening uptake among AGYW in Tanzania. This was a cross-sectional analysis of the 2022 Tanzania Demographic and Health Survey (2022 TDHS). The study population included AGYW aged 15–24 years. The outcome variable was HIV screening. Modified Poisson regression analysis was used to identify factors associated with HIV screening among AGYW. A total of 5,852 AGYW with a mean age of 19.3 ± 2.8 years were included in the analysis. The prevalence of ever “HIV screening” was 60.2% (95% CI: 58.4–61.9). Factors associated with a higher prevalence of HIV screening included older age 20–24 years (adjusted Prevalence Ratio, aPR 1.09, 95% CI 1.04–1.15), currently or previously in marital union (aPR 1.21, 95% CI 1.15–1.27), history of sexual intercourse (aPR 2.32, 95% CI 2.04–2.63), pregnancy history (aPR 1.43, 95% CI 1.35–1.52), awareness of sexually transmitted infections (aPR 1.16, 95% CI 1.10–1.22), awareness of HIV testing kits (aPR 1.08, 95% CI 1.03–1.13), condom use (aPR 1.07, 95% CI 1.02–1.12), ownership of telephone (aPR 1.14, 95% CI 1.09–1.19 for non-smartphone; aPR 1.25, 95% CI 1.13–1.37 for smartphone), and visiting a healthcare facility in the previous 12 months (aPR 1.18, 95% CI 1.13–1.24). Geographical differences showed that women in the Northern and Central zones (aPR 0.88, 95% CI 0.81–0.96) had a lower prevalence of HIV screening compared to those in the Eastern zone. The study revealed a sub-optimal prevalence of ever HIV screening among AGYW in Tanzania and was associated with different individual and interpersonal factors. Targeted interventions that address individual and interpersonal factors to improve HIV screening rates among AGYW should be implemented.

7 April 2023 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
PKPeter M. Karoli
Peter M. Karoli
GSGrace A. Shayo
Grace A. Shayo
ESElizabeth H. Shayo
Elizabeth H. Shayo
CWChristine V. Wood
Christine V. Wood
TOTheresia Ambrose Ottaru
Theresia Ambrose Ottaru
LHLisa Hirschhorn
Lisa Hirschhorn
While viral load (VL) testing is critical to effective treatment of human immunodeficiency virus (HIV), little is known about patients’ experiences with, and barriers to VL-testing in the context of HIV infection. We assessed patient reported experience measures (PREMs) on VL-testing in public HIV clinics in Tanzania. In a cross-sectional convergent mixed method study, we collected information on VL test related PREMs, clinical and sociodemographic factors. PREMs were measured using a 5-point Likert scale. Focus Group Discussions (FGDs) explored on experience, access, and barriers to VL-testing. Descriptive statistics summarized patients’ factors and PREMs. Logistic regression was used to explore association of patient factors, PREMs and satisfaction with VL-testing services. Thematic analysis was used for qualitative data. A total of 439 (96.48%) respondents completed the survey, 331 (75.40%) were female, median (IQR) age was 41(34, 49) years. A total of 253(57.63%) had a VL test at least once in the past 12 months, of whom 242(96.0%) had VL92.0%) reported good or very good health services responsiveness (HSR). A scale of very good was chosen by the majority for being treated with respect 174(39.6%), listened to 173(39.4%), following advice 109(24.8%), being involved in decisions 101(23.0%), and for communication 102(23.3%). Satisfaction on VL-testing services was significantly associated with respondents following care providers’ advice, (aOR) = 2.07 [95%CI 1.13–3.78], involvement in decisions aOR = 4.16 [95%CI 2.26–7.66], and communication aOR = 2.27 [95%CI 1.25–4.14]. FGDs findings converged with the survey data, with identified barriers to VL test including lack of autonomy in decision making, little awareness on the benefits of the test, long waiting time, stigma, competing priorities for those with comorbidities and transport costs. Satisfaction on VL-testing was largely a result of involvement in decision making, following care provider’s advice and good communication; entities needing universal improvement across the country.